Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 333-339

  Tang, Zhuobin ^a   Zhao, Min ^a   Ji, Jtafu ^a   Yang, Guibin ^a   Hu, Fulian ^a   He, Jingsheng ^b   Shen, Hui ^a   Gao, Zhian ^b   Zhao, Ailian ^b   Li, Jiyou ^b   Lu, Youyong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

C met protein; Gastric carcinomas; Gastrin; Intestinal metaplasia

Indexed keywords

GASTRIN; SCATTER FACTOR RECEPTOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; FEMALE; GENETICS; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE; RETROSPECTIVE STUDY; SMALL INTESTINE; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTRIC MUCOSA; GASTRINS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; METAPLASIA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MET; REFERENCE VALUES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 3242812199     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.333     Document Type: Article

References (67)

1. Ries LA, Eisner MP, Kosary CL, et al: SEER cancer statistics review. National Cancer Institute, Bethesda, MD, USA, pp1973-1997, 2000.
2. Becker KF, Keller G and Hoefler H: The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9: 5-11, 2000.
3. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35: 111-115, 2000. (Pubitemid 30229730)
4. Laurèn P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbio Scand 64: 31-49, 1965.
5. Soleia E, Vassallo G and Sampietro R: Endocrine cells in the antro-pyloric mucosa of the stomach. Z Zellforscb Mikrosk Anat 81: 474-486, 1967.
6. Forte J and Wolsin JM: HCl secretion by the gastric oxyntic cells. In: Physiology of the Gastrointestinal Tract. Johnson LR (Ed). Vol. 1, 2nd edition, Raven, New York, pp853-863, 1987.
7. Solomon TE: Control of exocrine pancreatic secretion. In: Physiology of Gastrointestinal Tract. Johnson LR (Ed). Vol. 2, Raven, New York, pp1173-1208, 1987.
8. Moran TH, Sawyer TK, Seeb DH, Ameglio PJ, Lombard MA, and McHugh PR: Potent and sustained satiety actions of a cholecystokiknin octapeptide analogue. Am J Clin Nutr 55: S286-S290, 1992.
9. Dembinski AB and Johnson LR: Growth of the pancreas and gastrointestinal mucosa by secretin, caerulein, and pentagastrin, Endocrinology 106: 323-328, 1980. (Pubitemid 10212503)
10. Majumdar A and Johsin L: Gastric mucosal cell proliferation during development in rats and effects of gastrin. Am J Physiol 242: 135-139, 1982.
11. Upp JR Jr, Singh P, Townsend CM Jr and Thompson JC: Clinical significance of gastrin receptors in human colon cancers. Cancer Res 49: 488-492, 1989. (Pubitemid 19049548)
12. Smith JP, Stock EA, Wotring MG, McLaughlin PJ and Zagon IS: Characterization of the CCK-B/gastrin-like receptor in human colon cancer. Am J Physiol 271: 797-805, 1996.
13. Winsett OE, Townsend CM, Glass EJ and Thompson JC: Gastrin stimulates growth of colon cancer. Surgery 99: 302-307, 1986. (Pubitemid 16026973)
14. Smith JP, Fantaskey AP, Liu G and Zagon IS: Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 268: 135-141, 1995.
15. Ishizuka J, Martinez J, Townsend CM Jr and Thompson JC: The effect of gastrin on growth of human stomach cancer cells. Ann Surg 215: 528-554, 1992.
16. Smith JP, Shih AH, Wotring MG, McLaughlin PJ and Zagon IS: Characterization of CCK-B/gastrin-like receptor in human gastric carcinoma. Int J Oncol 12: 411-419, 1998. (Pubitemid 28064870)
17. 2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res 52:6031-6035,1992.
18. Smith JP and Solomon TE: Effects of gastrin, proglumide and somatostatine on growth of human colon cancer. Gastroenterology 95: 1541-1548, 1988.
19. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF and Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991. (Pubitemid 21926175)
20. Trusolino L, Pugliese L and Comoglio PM: Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J 12: 1267-1280, 1998. (Pubitemid 28475569)
21. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M and Comoglio PM: The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10: 739-749, 1995.
22. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I and Dean M, et al: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997. (Pubitemid 27198158)
23. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B and Vande Woude GF: Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 94: 11445-11450, 1997. (Pubitemid 27451018)
24. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T and Nakano H: The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas. Cancer 85: 1894-1902, 1999. (Pubitemid 29202761)
25. Park WS, Oh RR, Kim YS, Park JY, Shin MS, Lee HK, Lee SH, Yoo NJ and Lee JY: Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas. APMIS 108: 195-200, 2000. (Pubitemid 30158999)
26. Wu CW, Li AF, Chi CW, Chung WW, Liu TY, Lui WY and Péng FK: Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. Oncol Rep 5: 817-822, 1998. (Pubitemid 28270673)
27. Shih C, Padhy LC, Murray M and Weinberg RA: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-264, 1981. (Pubitemid 11149660)
28. Perantoni AO, Rice JM, Reed CD, Watatani M and Wenk ML: The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312: 513-516, 1984.
29. Akiyama T, Sudo C, Ogawara H, Toyoshima K and Yamamoto T: The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 233: 1644-1646, 1986. (Pubitemid 16095607)
30. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, et al: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139, 1985. (Pubitemid 16169997)
31. Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A and Coussens L: The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: 976-978, 1985. (Pubitemid 16248489)
32. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB and Yarden Y: Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216, 1992.
33. Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM and Levy RB, et al: Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69: 559-572, 1992.
34. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, et al: Identification of heregulin, a specific activator of p185erbB2. Science 256: 1205-1210, 1992.
35. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987. (Pubitemid 17231334)
36. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989. (Pubitemid 19147683)
37. Park JB, Rhim JS, Park SC, Kimm SW and Kraus MH: Amplification, overexpression and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res 49: 6605-6609, 1989. (Pubitemid 20008795)
38. Sanz-Ortega J, Steinberg SM, Moro E, Saez M, Lopez JA, Sierra E, Sanz-Esponera J and Merino MJ: Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol 15: 455-462, 2000. (Pubitemid 30218839)
39. Gong Z, Luo E and Lu Q: Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma. Zhonghua Zhong Liu Za Zhi 18:299-301, 1996. (Pubitemid 26315543)
40. Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC Jr, LiVolsi VA and Greene MI: Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 4: 81-88, 1989. (Pubitemid 19085073)
41. Kristiansen G, Yu Y, Petersen S, Kaufmann O, Schluns K, Dietel M and Petersen I: Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer. Eur J Cancer 37: 1089-1095, 2001.
42. Mizutani T, Onda M, Tokunaga A, Yamanaka N and Sugisaki Y: Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 72: 2083-2088, 1993. (Pubitemid 23280130)
43. Venter DJ, Tuzi NL, Kumar S and Gullick WJ: Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 2: 69-72, 1987.
44. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998. (Pubitemid 28331029)
45. Kallioniemi OP, Wagner U, Kononen J and Sauter G: Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10: 657-662, 2001. (Pubitemid 32331572)
46. Schoenberg Fejzo M and Slamon DJ: Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol 159: 1645-1650, 2001.
47. Hermanek P and Sobin LH: UICC TNM Classification of Malignant Tumors. 4th edition, 2nd revision, Springer, London, 1992.
48. Ikeguchi M, Saito H, Katano K, Gomyo Y, Tsujitani S, Maeta M and Kaibara N: Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and MDM2 in patients with gastric carcinoma at stage IIIa and stage IIIb. Int Surg 82: 170-174, 1997. (Pubitemid 27443024)
49. Watson SA, Durrant LG, Wencyk PM, Watson AL and Morris DL: Intracellular gastrin in human gastrointestinal tumor cells. J Natl Cancer Inst 83: 866-871, 1991.
50. Watson SA, Michaeli D, Grimes S, Morris TM, Robinson G, Varro A, Justin TA and Hardcastle JD: Gastrimmune raises antibodies that neutralize amidated and glycine extended gastrin-17 and inhibits growth of colon cancer. Cancer Res 56: 880-885, 1996.
51. Watson SA, Michael D, Justin TA, Grimes S, Morris TM, Robinson G, Clarke PA and Hardcastle JD: Pre-clinical evaluation of gastrimmune immunogen alone and in combination with 5-fluoracil/leucovorin in a rat colorectal cancer model. Int J Cancer 75: 873-877, 1998. (Pubitemid 28134112)
52. Watson SA, Durrant LG and Morris DL: Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg 75: 342-345, 1988.
53. Blackmore M and Hirst BH: Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br J Cancer 66: 32-38, 1992.
54. Szabó I, Rumi G, Bódis B, Németh P and Mózsik G: Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells. J Physiol 94: 71-74, 2000.
55. Watson S, Durrant L and Morris D: Gastrin: growth-enhancing action of gastrin on human gastric and colonic tumour cells. Br J Cancer 59: 554-558, 1989. (Pubitemid 19111745)
56. Sumiyoshi H, Yasui W, Ochiai A and Tahara E: Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res 44: 4276-4280, 1984. (Pubitemid 14008734)
57. Singh P, Dai B, Wu H and Owilia A: Role of autocrine and endocrine gastrin-like peptides in colonic carcinogenesis. Curr Opin Gastroenterol 16: 68-77, 2000. (Pubitemid 30398612)
58. Tang ZB and Liu WW: Effects of gastrin G-17 and its antagonist L-365260 on the growth of human gastric cancer cell line SGC-7901 (in Chinese). Acta Academiae Medicinae Militaris Tertiae 23: 17-19, 2001.
59. Tokunaga A, Onda M, Okuda T, Teramoto T, Fujita I, Mizutani T, Kiyama T, Yoshiyuki T, Nishi K and Matsukura N: Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer 75: 1418-1425, 1995.
60. Wei Z, Wu Y and Zhai Z: Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer. Zhonghua Zhong Liu Za Zhi 19: 378-381, 1997.
61. Blok P, Craanen ME, Dekker W, Offerhaus GJ and Tytgat GN: No evidence for c-erbB-2 overexpression in gastric carcinogenesis. Histopathology 32: 335-339, 1998. (Pubitemid 28186592)
62. Gurel S, Dolar E, Yerci O, Samli B, Ozturk H, Nak SG, Gulten M and Memik F: The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer. J Int Med Res 27: 74-78, 1999. (Pubitemid 29346813)
63. Danesi DT, Spano M, Fabiano A, Altavista P, Pasqualetti P, Toscano MG, Antonini F, Catalano P, Mecozzi A, Picconi A, et al: Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients. Cytometry 42: 27-34, 2000. (Pubitemid 30131400)
64. Howell GM, Ziober BL, Humphrey LE, Willson JK, Sun L, Lynch M and Brattain MG: Regulation of autocrine gastrin expression by the TGF alpha autocrine loop. J Cell Physiol 162: 256-265, 1995.
65. Tsutsui S, Shinomura Y, Higashiyama S, Higashimoto Y, Miyazaki Y, Kanayama S, Hiraoka S, Minami T, Kitamura S, Murayama Y, et al: Induction of heparin binding epidermal growth factor-like growth factor and amphiregulin mRNAs by gastrin in the rat stomach. Biochem Biophys Res Commun 235: 520-523, 1997. (Pubitemid 27326512)
66. Miyazaki Y, Shinomura Y, Tsutsui S, Zushi S, Higashimoto Y, Kanayama S, Higashiyama S, Taniguchi N and Matsuzawa Y: Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor. Gastroenterology 116: 78-89, 1999. (Pubitemid 29013496)
67. Vidgren V, Varis A, Kokkola A, Monni O, Puolakkainen P, Nordling S, Forozan F, Kallioniemi A, Vakkari ML, Kivilaakso E, et al: Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer. Genes Chromosomes Cancer 24: 24-29, 1999. (Pubitemid 28544459)